Mimio Health

Welcome to Fasting 2.0

United States · Founded 2020 · $1.8M raised

Employees
1–10
Founded
2020
Total Funding
$1.8M
Last Round
$1.8M SeedMar 2023
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. The full record is or through the API.

About

Mimio Health is a nutraceutical company pioneering the world's first fasting mimetic supplement, designed from seven years of human clinical research to replicate the cellular health and longevity benefits of a 36-hour fast without requiring dietary restriction. The company's patent-pending formulation delivers a rigorously selected combination of bioactive fasting metabolites that activate the body's natural cellular repair pathways — including autophagy, AMPK, and SIRT — to reduce biological age, support healthy glucose and cholesterol levels, and improve energy and cognitive performance. Mimio has demonstrated a 96% lifespan extension in model organisms and has been featured in Rolling Stone, TechCrunch, Men's Journal, and Vogue. Products are vegan, gluten-free, GMO-free, GMP-certified, and sold direct-to-consumer.

Summary

Mimio Health is a Biotech company based in United States, founded in 2020. It has raised $1.8M in total across 1 round, most recently a $1.8M Seed round in Mar 2023. Investors include better ventures, 10X Capital and AgFunder.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundMar 2023
$1.8M

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
CertaraIPO

Global biosimulation software and services company accelerating drug development for 2,000+ bioph...

Radnor, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$1.3BDec 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Mimio Health on Indexed.vc
<a href="https://indexed.vc/companies/mimio-health"><img src="https://indexed.vc/api/badge/company/mimio-health" alt="Mimio Health on Indexed.vc" width="260" height="76" /></a>